Skip to main content
OpenTrials
Completed

NCT Number: NCT05991635

Evaluation of a Gatekeeper Training for Pharmacists

This study aims to investigate to what extent a gatekeeper training (e-learning) for pharmacists and PTA is effective in changing the attitudes, knowledge, and self-efficacy. Moreover, it aims to examine how they evaluate the training and whether they were able to apply the learned skills in practice.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Suicide Behavior Behavioral Symptoms Self-Injurious Behavior

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Flemish Centre of Expertise in Suicide Prevention, Ghent University

Ghent, 9000, Belgium

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • ≥ 18 years old
  • Have access to internet
  • Speak Dutch
  • Working as a (public) pharmacist or pharmaceutical technical assistant (FTA)

Exclusion criteria

  • Hospital pharmacists or industrial pharmacists are not included in this study and thus constitute an exclusion criterion.

Treatment and study plan

Gatekeeper training (e-learning)

Behavioral

The gatekeeper training consists of an interactive e-learning (min. 1h, max. 3h) which includes theoretical knowledge, tips, exercises and relevant examples and cases. The main topics included in the e-learning are:

  • Background information on suicide in Flanders (rates)
  • Definitions and theoretical background (suicidal process, integrative explanatory model of suicide)
  • Debunking existing myths about suicide
  • The role of the pharmacist in suicide prevention
  • Signal Recognition
  • Talking about suicide and suicidal thoughts (start the conversation)
  • How and to whom to refer as pharmacist or FTA
  • Medication management and medication in the context of suicide
  • Rights and obligations of a pharmacist/PTA in the context of suicide prevention
  • Self-care

Primary outcomes

  1. Changes in attitudes: Attitudes Towards Suicide Scale (ATTS)

    Time frame: Change from Baseline (before intervention) to post-test (after a week of access to e-learning)

    The ATTS is a 37-item to be scored on a 5-point Likert scale (1= disagree completely to 5 = agree completely) to measure participants' attitudes towards suicide.

Secondary outcomes

  1. Changes in self-efficacy: Measurement of Perceived Self-efficacy

    Time frame: Change from Baseline (before intervention) to post-test (after a week of access to e-learning)

    The Measurement of Perceived Self-efficacy is a 10-item self-report questionnaire to be scored on a 4-point Likert scale (1= Completely false to 4 = completely true)

  2. Changes in perceptions/myths

    Time frame: Change from Baseline (before intervention) to post-test (after a week of access to e-learning)

    Self-developped questionnaire: 4 statements to be rated as true or false; 2 question about how participant would feel if a patient said they have suicidal thouhgts

  3. Gatekeeper training evaluation

    Time frame: Post-test (after a week of access to e-learning)

    8 evaluative statements about the e-learning to be rated on a 5-point Likert scale (Totally disagree, disagree, neutral, agree, totally disagree).

    Question to rate the e-learning on a scale of 1 (not good at all) to 10 (excellent) Additionally three open questions where participants can give feedback about what they liked/did not like/ general comments.

Other outcomes

  1. Socio-demographic characteristics

    Time frame: Baseline

    Age, Gender, Years of work experience

  2. Previous experience with suicide (prevention)

    Time frame: Baseline and post-test (after a week of access to e-learning)

    At baseline: motivation to participate (9 options), previous trainings (yes/no, specify if yes) At baseline and post-test: experience with suicidal patients (contact and confidence; 5 point Likert scale), knowing what to do or who to refer to (5-point Likert scale), knowing where to find information (5-point Likert scale), which actions previously taken in case of suicidal patient (list of 12), to who do you refer (5 options)

  3. Follow-up

    Time frame: Follow-up (three months after baseline)

    Questions concerning: application of acquired skills and knowledge; actions undertaken in context of suicide prevention (12 options); experienced barriers to application of acquired skills and knowledge; need of extra support

Sponsors and collaborators

Lead sponsor

University Ghent

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Aug 14, 2023
Registry last updated
Feb 6, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.